High level of BMI1 is associated with medulloblastoma invasion [29] and is also considered to be a poor prognostic marker in multiple human cancers [30-34], and is significantly involved in chemoresistance and tumor recurrence [35-38]. This evidence concerns the gene BMI1 and medulloblastoma.